Xylooligosaccharides (XOS)

Evidence Level
Moderate
3 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Xylooligosaccharides (XOS) are short-chain prebiotic carbohydrates produced from plant arabinoxylan sources such as corn cobs, wheat bran, or birch wood, typically containing 2-7 xylose units linked by beta-1,4 bonds. XOS are fermented preferentially by Bifidobacterium species in the colon, increasing bifidobacterial counts at very low effective doses — often as little as 1-2 grams per day — compared with many other prebiotics. Randomized controlled trials in healthy adults have shown that daily XOS supplementation can increase fecal bifidobacteria, modulate selected immune markers, and improve aspects of bowel function with generally good tolerability. XOS is widely used in functional foods, prebiotic blends, and gut-health supplements.

Studied Dose 1-4 g/day in healthy adults; bifidogenic effects reported from 1.4 g/day.
Active Compound Beta-1,4-linked xylose oligomers with 2-7 xylose units (xylobiose, xylotriose, xylotetraose, etc.), often with some arabinose side groups.

Benefits

Supports bifidobacterial growth at low doses

XOS has been shown in randomized human trials to selectively increase fecal Bifidobacterium counts at doses as low as 1-2 grams per day, helping support a beneficial bacterial profile in the colon with minimal change in total carbohydrate intake.

Helps maintain regular bowel function

Daily XOS supplementation has been associated in human studies with improvements in bowel function indicators such as stool consistency and frequency, supporting comfortable, regular elimination in adults.

Supports gut-immune crosstalk

Trials of XOS, alone and in synbiotic combinations with bifidobacteria, have shown modulation of selected serum and mucosal immune markers, supporting the role of XOS in the broader gut-immune axis.

Effective at small serving sizes

Because XOS is highly bifidogenic per gram, target effects can often be achieved with sub-5-gram daily servings, reducing the bloating and gas burden sometimes seen with higher-dose prebiotics.

Stable in functional foods and beverages

XOS is stable to heat and acidic conditions found in many foods and beverages, supporting its use as a prebiotic ingredient in yogurts, drinks, bars, and supplement blends without significant degradation during processing.

Mechanism of action

1

Selective bifidobacterial fermentation

Bifidobacterium species possess transport systems and xylosidase enzymes that allow efficient uptake and fermentation of XOS, giving them a competitive advantage over many other gut microbes when XOS is supplied in the colon.

2

Short-chain fatty acid production

Fermentation of XOS by gut microbes generates short-chain fatty acids, particularly acetate and lactate, which contribute to lower colonic pH, support colonocyte energy supply, and influence local immune signaling.

3

Colonic pH and pathogen competition

By lowering colonic pH and shifting microbial composition toward bifidobacteria and lactobacilli, XOS may help create a less favorable environment for some potential pathogens and putrefactive bacteria.

4

Immune modulation via gut signaling

Changes in microbial composition and short-chain fatty acid output from XOS fermentation can modulate signaling between gut microbes and immune cells in gut-associated lymphoid tissue, contributing to systemic immune marker changes seen in trials.

Clinical trials

1
XOS bifidogenic RCT in healthy adults

Randomized, double-blind, placebo-controlled trial; 21 days; XOS alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis vs placebo.

Healthy adults.

XOS supplementation, alone and in combination with the probiotic, increased fecal bifidobacteria and modulated markers of immune function compared with placebo, supporting selective bifidogenic and immunomodulatory effects of XOS in healthy adults.

2
XOS and inulin RCT on microbiota and immunity

Randomized, double-blind, placebo-controlled trial; 4 weeks; XOS alone, XOS plus inulin, or placebo.

60 healthy volunteers.

XOS alone showed prebiotic effects on intestinal microbiota, and combining XOS with inulin further modulated intestinal environment and selected immune status markers, supporting the prebiotic profile of XOS at relatively low doses.

3
Low-dose XOS and bifidobacteria in healthy adults

Randomized, double-blind, placebo-controlled trial; 8 weeks; low-dose XOS supplementation.

32 healthy adults.

Low-dose XOS supplementation significantly increased fecal bifidobacteria compared with placebo without significantly affecting Lactobacillus counts, supporting selective bifidogenic activity of XOS even at modest daily intakes.

Side effects and drug interactions

Common Potential side effects

Mild bloating or gas, especially in the first days of supplementation.
Loose stools or mild diarrhea at higher than recommended doses.
Abdominal cramping in sensitive users when titrated up too quickly.
Possible flare of symptoms in some users with IBS or FODMAP intolerance.
Generally well tolerated at typical doses of 1-4 g/day in healthy adults.

Important Drug interactions

No major direct drug interactions reported with XOS in clinical studies.
May alter timing of oral antibiotic effects on gut microbiota; separate dosing recommended.
Discuss with a clinician if combining with strong immunosuppressants such as ciclosporin.
Use cautiously alongside laxatives to avoid additive loose-stool effects.

Frequently asked questions about Xylooligosaccharides (XOS)

What is XOS (xylooligosaccharides)?

XOS are prebiotic fibers made from xylan (a plant fiber). They are notable because they are effective at very low doses, selectively feeding beneficial bacteria like bifidobacteria with less gas than some other prebiotics.

Why is XOS used at lower doses than other prebiotics?

XOS is a potent, selective prebiotic, so meaningful effects on bifidobacteria are seen at just 1 to 4 grams per day, much less than inulin or FOS. This lower dose also means it tends to cause less gas and bloating.

What is XOS used for?

XOS is used as a gentle, low-dose prebiotic to support a healthy gut microbiome and regularity. It is increasingly popular in fiber and synbiotic products for its tolerability.

Is XOS safe?

XOS is safe and generally well tolerated, often better than higher-dose prebiotics. As with any fiber, very large amounts can cause digestive upset, so follow product labeling.

What is Xylooligosaccharides?

Xylooligosaccharides (XOS) are short-chain prebiotic carbohydrates produced from plant arabinoxylan sources such as corn cobs, wheat bran, or birch wood, typically containing 2-7 xylose units linked by beta-1,4 bonds.

What is Xylooligosaccharides used for?

Xylooligosaccharides is researched primarily for Gut Health and Immune Support. XOS has been shown in randomized human trials to selectively increase fecal Bifidobacterium counts at doses as low as 1-2 grams per day, helping support a beneficial bacterial profile in the colon with minimal change in total carbohydrate i…

What is the recommended dosage of Xylooligosaccharides?

The clinically studied dose is 1-4 g/day in healthy adults; bifidogenic effects reported from 1.4 g/day. Always follow the product label and check with a healthcare provider for personal advice.

Is Xylooligosaccharides safe, and does it have side effects?

For most healthy adults, Xylooligosaccharides is well tolerated at studied doses. Reported effects can include: Mild bloating or gas, especially in the first days of supplementation. Loose stools or mild diarrhea at higher than recommended doses. It may also interact with some medications. Xylooligosaccharides is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Xylooligosaccharides interact with any medications?

Possible interactions include: No major direct drug interactions reported with XOS in clinical studies. May alter timing of oral antibiotic effects on gut microbiota; separate dosing recommended. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Xylooligosaccharides?

NutraSmarts rates the evidence for Xylooligosaccharides as Moderate (3 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Childs CE, Röytiö H, Alhoniemi E, Fekete AA, Forssten SD, Hudjec N, Lim YN, Steger CJ, Yaqoob P, Tuohy KM, Rastall RA, Ouwehand AC, Gibson GR. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. British Journal of Nutrition. 2014;111(11):1945-56.PubMedUsed to support: RCT: XOS alone and in synbiotic combination with B. lactis increased fecal bifidobacteria and modulated immune markers in healthy adults, supporting selective bifidogenic and immunomodulatory effects.
  2. Lecerf JM, Dépeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H, Jacobs H, Lambrey G, Abdelnour AM, Pouillart PR. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. British Journal of Nutrition. 2012;108(10):1847-58.PubMedUsed to support: RCT in 60 healthy adults: XOS alone showed prebiotic effects on intestinal microbiota; XOS plus inulin further modulated intestinal environment and immune status markers.
  3. Finegold SM, Li Z, Summanen PH, Downes J, Thames G, Corbett K, Dowd S, Krak M, Heber D. Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food & Function. 2014;5(3):436-45.PubMedUsed to support: 8-week RCT in 32 healthy adults: low-dose XOS significantly increased fecal Bifidobacterium counts without significantly affecting Lactobacillus counts, supporting selective bifidogenic activity.